Credit Suisse’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$102M Sell
306,195
-16,504
-5% -$5.04M 0.1% 195
2023
Q4
$87.3M Buy
322,699
+676
+0.2% +$167K 0.08% 226
2023
Q3
$79.2M Buy
322,023
+5,131
+2% +$1.4M 0.08% 251
2023
Q2
$96.2M Sell
316,892
-49,327
-13% -$13.7M 0.1% 212
2023
Q1
$96.6M Sell
366,219
-18,364
-5% -$4.66M 0.1% 208
2022
Q4
$92.3M Sell
384,583
-2,962
-0.8% -$663K 0.1% 218
2022
Q3
$71.2M Sell
387,545
-320,251
-45% -$63.8M 0.08% 262
2022
Q2
$119M Buy
707,796
+272,938
+63% +$58.6M 0.12% 169
2022
Q1
$109M Buy
434,858
+30,217
+7% +$7.59M 0.09% 229
2021
Q4
$104M Sell
404,641
-4,957
-1% -$1.21M 0.06% 349
2021
Q3
$99.4M Sell
409,598
-36,567
-8% -$8.94M 0.05% 371
2021
Q2
$91.9M Sell
446,165
-15,984
-3% -$3.26M 0.05% 415
2021
Q1
$87M Buy
462,149
+21,327
+5% +$3.76M 0.04% 456
2020
Q4
$72.5M Sell
440,822
-70,216
-14% -$10.3M 0.04% 540
2020
Q3
$63.7M Sell
511,038
-81,437
-14% -$10.1M 0.04% 516
2020
Q2
$57.5M Buy
592,475
+25,808
+5% +$2.68M 0.04% 480
2020
Q1
$50.9M Sell
566,667
-1,183
-0.2% -$153K 0.04% 432
2019
Q4
$83.9M Buy
567,850
+124,208
+28% +$16.7M 0.06% 339
2019
Q3
$53.4M Buy
443,642
+28,904
+7% +$3.74M 0.05% 429
2019
Q2
$56.1M Sell
414,738
-61,789
-13% -$7.81M 0.05% 392
2019
Q1
$62.1M Buy
476,527
+45,620
+11% +$6.13M 0.06% 335
2018
Q4
$53.6M Sell
430,907
-12,363
-3% -$1.66M 0.06% 357
2018
Q3
$61.7M Sell
443,270
-1,205
-0.3% -$150K 0.06% 348
2018
Q2
$45.6M Buy
444,475
+18,075
+4% +$1.83M 0.04% 423
2018
Q1
$41.4M Sell
426,400
-84,184
-16% -$8.17M 0.04% 491
2017
Q4
$44.8M Sell
510,584
-8,577
-2% -$689K 0.04% 481
2017
Q3
$41.3M Buy
519,161
+30,994
+6% +$2.49M 0.04% 484
2017
Q2
$42.6M Sell
488,167
-90,113
-16% -$7.62M 0.04% 463
2017
Q1
$51.5M Sell
578,280
-31,103
-5% -$2.59M 0.05% 423
2016
Q4
$45.1M Buy
609,383
+6,674
+1% +$500K 0.04% 452
2016
Q3
$45.6M Buy
602,709
+16,502
+3% +$1.26M 0.04% 469
2016
Q2
$45.1M Buy
586,207
+30,123
+5% +$2.38M 0.05% 415
2016
Q1
$43.4M Sell
556,084
-1,063,026
-66% -$74.2M 0.05% 402
2015
Q4
$110M Buy
1,619,110
+403,457
+33% +$28.1M 0.13% 163
2015
Q3
$94M Buy
1,215,653
+51,509
+4% +$4.56M 0.11% 183
2015
Q2
$106M Sell
1,164,144
-166,672
-13% -$13.4M 0.1% 202
2015
Q1
$100M Buy
1,330,816
+19,328
+1% +$1.39M 0.1% 209
2014
Q4
$96.2M Sell
1,311,488
-366,803
-22% -$25.8M 0.09% 229
2014
Q3
$118M Buy
1,678,291
+284,597
+20% +$18.8M 0.1% 207
2014
Q2
$78.6M Buy
1,393,694
+20,770
+2% +$1.1M 0.06% 301
2014
Q1
$72.1M Buy
1,372,924
+641,131
+88% +$31.9M 0.07% 282
2013
Q4
$34.9M Sell
731,793
-87,087
-11% -$4.02M 0.03% 556
2013
Q3
$35M Sell
818,880
-52,590
-6% -$2.05M 0.03% 477
2013
Q2
$31.4M Buy
+871,470
New +$33.7M 0.03% 550

Other funds holding HCA

Credit Suisse's HCA Position: Q1 2024 in Review

Credit Suisse reduced its HCA Healthcare (HCA) stake by 5.1% in Q1 2024, selling an estimated $5.04M and leaving 306,195 shares worth $102M. The position accounts for 0.1% of the portfolio, ranked #195.

Credit Suisse first reported a position in HCA in Q2 2013 and has held it in 44 quarters since. The position peaked at $119M in Q2 2022. 1,126 funds tracked by Wall St. Rank hold HCA as of Q1 2024.

  • Credit Suisse held 306,195 shares of HCA Healthcare worth $102M as of Q1 2024.
  • Credit Suisse sold 16,504 HCA Healthcare shares in Q1 2024, an estimated $5.04M.
  • HCA Healthcare made up 0.1% of Credit Suisse's portfolio in Q1 2024, its #195 holding.
  • Credit Suisse first reported a position in HCA Healthcare in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's HCA Healthcare position peaked at $119M in Q2 2022.
  • 1,126 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.